{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:51:15Z","timestamp":1760143875394,"version":"build-2065373602"},"reference-count":28,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>The history of thymoma (TH) research begins in the early 20th century, when Bell first recognized the epithelial nature of these tumors and their association with myasthenia gravis (MG) [...]<\/jats:p>","DOI":"10.3390\/cancers16051040","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T04:36:21Z","timestamp":1709526981000},"page":"1040","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Way Ahead: Lessons Learned from Decades of Cancer Research on Thymomas and Thymic Carcinomas"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8528-8060","authenticated-orcid":false,"given":"Philipp","family":"Str\u00f6bel","sequence":"first","affiliation":[{"name":"Institute of Pathology, University Medical Center G\u00f6ttingen, D-37075 G\u00f6ttingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Marx","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Medical Center G\u00f6ttingen, D-37075 G\u00f6ttingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,3,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00005053-191702000-00002","article-title":"Tumors or the thymus in myasthenia gravis","volume":"45","author":"Bell","year":"1917","journal-title":"J. Nerv. Ment. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0046-8177(78)80131-2","article-title":"Thymic hyperplasia and neoplasia: A review of current concepts","volume":"9","author":"Levine","year":"1978","journal-title":"Hum. Pathol."},{"key":"ref_3","unstructured":"Marx, A., and Chan, J.K.C. (2021). Tumors of the thymus: Introduction, WHO Classification of Tumours. Thoracic Tumours."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/labinvest.2012.115","article-title":"Establishment and characterization of a novel cell line derived from human thymoma AB tumor","volume":"92","author":"Sanders","year":"2012","journal-title":"Lab. Investig."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.21037\/tcr.2018.12.12","article-title":"Establishment and characterization of a novel cell line derived from type AB thymoma","volume":"7","author":"Sun","year":"2018","journal-title":"Transl. Cancer Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/1759-7714.12163","article-title":"Establishment and characterization of a novel cell line derived from thymoma with myasthenia gravis patients","volume":"6","author":"Wang","year":"2015","journal-title":"Thorac. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.21037\/jtd.2017.05.28","article-title":"Decreased Wnt4 expression inhibits thymoma development through downregulation of FoxN1","volume":"9","author":"Chen","year":"2017","journal-title":"J. Thorac. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1002\/ijc.23335","article-title":"Establishment, characterization and drug sensitivity testing in primary cultures of human thymoma and thymic carcinoma","volume":"122","author":"Ehemann","year":"2008","journal-title":"Int. J. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.jtho.2016.04.013","article-title":"PI3K as a Potential Therapeutic Target in Thymic Epithelial Tumors","volume":"11","author":"Alberobello","year":"2016","journal-title":"J. Thorac. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1111\/j.1349-7006.2008.00897.x","article-title":"Multiple inflammatory cytokine-productive ThyL-6 cell line established from a patient with thymic carcinoma","volume":"99","author":"Inai","year":"2008","journal-title":"Cancer Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/ng.3016","article-title":"A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors","volume":"46","author":"Petrini","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Giorgetti, O.B., Nusser, A., and Boehm, T. (2022). Human thymoma-associated mutation of the GTF2I transcription factor impairs thymic epithelial progenitor differentiation in mice. Commun. Biol., 5.","DOI":"10.1038\/s42003-022-04002-7"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jtho.2022.08.008","article-title":"A Knock-In Mouse Model of Thymoma With the GTF2I L424H Mutation","volume":"17","author":"He","year":"2022","journal-title":"J. Thorac. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ccell.2018.01.003","article-title":"The Integrated Genomic Landscape of Thymic Epithelial Tumors","volume":"33","author":"Radovich","year":"2018","journal-title":"Cancer Cell"},{"key":"ref_15","first-page":"2001","article-title":"Identification of potential agents for thymoma by integrated analyses of differentially expressed tumour-associated genes and molecular docking experiments","volume":"18","author":"Wang","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jtho.2021.02.008","article-title":"A Tuft Cell-Like Signature Is Highly Prevalent in Thymic Squamous Cell Carcinoma and Delineates New Molecular Subsets Among the Major Lung Cancer Histotypes","volume":"16","author":"Yamada","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/jcp.48.5.447","article-title":"Oncogene proteins and proliferation antigens in thymomas: Increased expression of epidermal growth factor receptor and Ki67 antigen","volume":"48","author":"Gilhus","year":"1995","journal-title":"J. Clin. Pathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/978-1-0716-0266-9_17","article-title":"Testing the Efficiency and Kinetics of Negative Selection Using Thymic Slices","volume":"2111","author":"Zhou","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.cell.2015.01.042","article-title":"Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy","volume":"160","author":"Montero","year":"2015","journal-title":"Cell"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.lungcan.2020.04.036","article-title":"Image-based ex vivo drug screen to assess targeted therapies in recurrent thymoma","volume":"145","author":"Arjonen","year":"2020","journal-title":"Lung Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13229-020-00387-6","article-title":"High-throughput screening identifies histone deacetylase inhibitors that modulate GTF2I expression in 7q11.23 microduplication autism spectrum disorder patient-derived cortical neurons","volume":"11","author":"Cavallo","year":"2020","journal-title":"Mol. Autism"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1097\/JTO.0000000000000269","article-title":"Development of the international thymic malignancy interest group international database: An unprecedented resource for the study of a rare group of tumors","volume":"9","author":"Huang","year":"2014","journal-title":"J. Thorac. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1097\/JTO.0000000000000296","article-title":"A practical guide from the International Thymic Malignancy Interest Group (ITMIG) regarding the radiographic assessment of treatment response of thymic epithelial tumors using modified RECIST criteria","volume":"9","author":"Benveniste","year":"2014","journal-title":"J. Thorac. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1097\/JTO.0000000000000290","article-title":"The IASLC\/ITMIG Thymic Epithelial Tumors Staging Project: Proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors","volume":"9","author":"Detterbeck","year":"2014","journal-title":"J. Thorac. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Brierley, J.D., Gospodarowicz, M.K., and Wittekind, C. (2016). TNM Classification of Malignant Tumours, Wiley-Blackwell. [8th ed.].","DOI":"10.1002\/9780471420194.tnmc26.pub3"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.annpat.2014.01.010","article-title":"[Rythmic-pathology: The French national pathology network for thymic epithelial tumours]","volume":"34","author":"Chalabreysse","year":"2014","journal-title":"Ann. Pathol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.cllc.2021.01.020","article-title":"RADIORYTHMIC: Phase III, Opened, Randomized Study of Postoperative Radiotherapy Versus Surveillance in Stage IIb\/III of Masaoka Koga Thymoma after Complete Surgical Resection","volume":"22","author":"Basse","year":"2021","journal-title":"Clin. Lung Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1038\/s41467-022-31951-8","article-title":"Myasthenia gravis-specific aberrant neuromuscular gene expression by medullary thymic epithelial cells in thymoma","volume":"13","author":"Yasumizu","year":"2022","journal-title":"Nat. Commun."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/5\/1040\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:08:55Z","timestamp":1760105335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/5\/1040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,4]]},"references-count":28,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["cancers16051040"],"URL":"https:\/\/doi.org\/10.3390\/cancers16051040","relation":{},"ISSN":["2072-6694"],"issn-type":[{"type":"electronic","value":"2072-6694"}],"subject":[],"published":{"date-parts":[[2024,3,4]]}}}